204 related articles for article (PubMed ID: 23302044)
21. Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site.
Khalil MO; Morton LM; Devesa SS; Check DP; Curtis RE; Weisenburger DD; Dores GM
Br J Haematol; 2014 Apr; 165(1):67-77. PubMed ID: 24417667
[TBL] [Abstract][Full Text] [Related]
22. Incidence of gastric involvement in patients with nongastrointestinal extranodal marginal zone lymphoma.
Mazloom A; Rodriguez A; Ha CS; Medeiros LJ; Wogan C; Shihadeh F; Allen P; Fowler N; Dabaja B
Cancer; 2011 Jun; 117(11):2461-6. PubMed ID: 24048794
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome for patients with early stage marginal zone lymphoma and mantle cell lymphoma.
Barzenje DA; Holte H; Fosså A; Ghanima W; Liestøl K; Delabie J; Kolstad A
Leuk Lymphoma; 2017 Mar; 58(3):623-632. PubMed ID: 27389974
[TBL] [Abstract][Full Text] [Related]
24. Marginal zone lymphomas.
Zucca E; Rossi D; Bertoni F
Hematol Oncol; 2023 Jun; 41 Suppl 1():88-91. PubMed ID: 37294969
[TBL] [Abstract][Full Text] [Related]
25. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
[TBL] [Abstract][Full Text] [Related]
26. Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
Juárez-Salcedo LM; Castillo JJ
Hematol Oncol Clin North Am; 2019 Aug; 33(4):639-656. PubMed ID: 31229160
[TBL] [Abstract][Full Text] [Related]
27. Is there role of additional chemotherapy after definitive local treatment for stage I/II marginal zone lymphoma?: Consortium for Improving Survival of Lymphoma (CISL) study.
Koh MS; Kim WS; Kim SJ; Oh SY; Yoon DH; Lee SI; Hong J; Song MK; Shin HJ; Kwon JH; Kim HJ; Do YR; Suh C; Kim HJ
Int J Hematol; 2015 Oct; 102(4):420-5. PubMed ID: 26210384
[TBL] [Abstract][Full Text] [Related]
28. Nongastric marginal zone B-cell lymphoma: a prognostic model from a retrospective multicenter study.
Oh SY; Kwon HC; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Bang SM; Kim JH; Park J; Ryoo BY; Lee SS; Kim HY; Park K; Kim HJ
Cancer Lett; 2007 Dec; 258(1):90-7. PubMed ID: 17936499
[TBL] [Abstract][Full Text] [Related]
29. Nongastric marginal zone B-cell lymphoma: analysis of 247 cases.
Oh SY; Ryoo BY; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Kim HJ; Kwon HC; Bang SM; Kim JH; Park J; Lee SS; Kim HY; Park K
Am J Hematol; 2007 Jun; 82(6):446-52. PubMed ID: 17266060
[TBL] [Abstract][Full Text] [Related]
30. Nodal marginal zone B-cell lymphoma: a diagnostic and therapeutic dilemma.
Traverse-Glehen A; Bertoni F; Thieblemont C; Zucca E; Coiffier B; Berger F; Salles G
Oncology (Williston Park); 2012 Jan; 26(1):92-9, 103-4. PubMed ID: 22393802
[TBL] [Abstract][Full Text] [Related]
31. Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study.
Luminari S; Merli M; Rattotti S; Tarantino V; Marcheselli L; Cavallo F; Varettoni M; Bianchi B; Merli F; Tedeschi A; Cabras G; Re F; Visco C; Torresan Delamain M; Cencini E; Spina M; Ferrero S; Ferrari A; Deodato M; Mannina D; Annibali O; Rago A; Orsucci L; Defrancesco I; Frigeni M; Cesaretti M; Arcaini L
Blood; 2019 Sep; 134(10):798-801. PubMed ID: 31292118
[TBL] [Abstract][Full Text] [Related]
32. Results of Upfront Therapy for Marginal Zone Lymphoma.
Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
[TBL] [Abstract][Full Text] [Related]
33. Transformation to diffuse large B-cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population-based study.
Du Y; Wang Y; Li Q; Chang X; Shen K; Zhang H; Xiao M; Xing S
Int J Cancer; 2024 Mar; 154(6):969-978. PubMed ID: 37874120
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and Pattern of Autoimmune Conditions in Patients with Marginal Zone Lymphoma: A Single Institution Experience.
Dasanu CA; Bockorny B; Grabska J; Codreanu I
Conn Med; 2015 Apr; 79(4):197-200. PubMed ID: 26259295
[TBL] [Abstract][Full Text] [Related]
35. Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study.
Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Kang HJ; Choi CW; Park J; Kim HJ; Kwon JH; Lee HS; Lee GW; Eom HS; Kwak JY; Suh C; Kim HJ
Cancer Sci; 2010 Nov; 101(11):2443-7. PubMed ID: 20831770
[TBL] [Abstract][Full Text] [Related]
36. Management of the marginal zone lymphomas.
Vannata B; Stathis A; Zucca E
Cancer Treat Res; 2015; 165():227-49. PubMed ID: 25655612
[TBL] [Abstract][Full Text] [Related]
37. Current Treatments in Marginal Zone Lymphoma.
Alderuccio JP; Kahl BS
Oncology (Williston Park); 2022 Apr; 36(4):206-215. PubMed ID: 35436062
[TBL] [Abstract][Full Text] [Related]
38. Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era.
Gutiérrez-García G; Colomo L; Villamor N; Arenillas L; Martínez A; Cardesa T; García-Herrera A; Setoain X; Rodríguez S; Ghita G; Abrisqueta P; Giné E; Bosch F; Campo E; Montserrat E; López-Guillermo A
Leuk Lymphoma; 2010 Jul; 51(7):1225-32. PubMed ID: 20497002
[TBL] [Abstract][Full Text] [Related]
39. Marginal zone B-cell lymphomas.
Sagaert X; Tousseyn T
Discov Med; 2010 Jul; 10(50):79-86. PubMed ID: 20670602
[TBL] [Abstract][Full Text] [Related]
40. [Current management of marginal zone lymphomas].
Bonnet C; Lejeune M; Van Kemseke C; Bron D; Beguin Y
Rev Med Suisse; 2015 Aug; 11(483):1549-56. PubMed ID: 26502581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
